Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples